Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL PK and Safety in Thoracotomy
NCT03428984Phase 1Terminated
- Sponsor
- Pacira BioSciences
- Start
- May 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Pacira BioSciences. Primary endpoint: Area Under the Curve of EXPAREL concentration. Started May 2018; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03428984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03428984.